Skip to content

Pilot Study of Lateral Rotation Interventions for Efficacy and Safety in ICU Care

Multi-site Randomized Clinical Trial of Horizontal Positioning to Prevent and Treat Pulmonary Complications in Mechanically Ventilated Critically Ill Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00542321
Enrollment
16
Registered
2007-10-11
Start date
2007-09-30
Completion date
2011-09-30
Last updated
2016-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia, Ventilator Associated

Keywords

lateral rotation, kinetic therapy, mechanical ventilation, pulmonary complications

Brief summary

Intensive care unit (ICU) patients on respirators are at high risk for preventable pulmonary complications (PPC). Turning these patients from side to side may reduce PPC, but carries the burden of decreases in blood pressure and oxygenation. The investigators hypothesize that there will be no difference in PPC or adverse events when ICU patients on respirators are turned by nurses or by an automated turning bed.

Detailed description

The purpose of this pilot study is to test the feasibility of two turning protocols and study procedures for a multi-site randomized clinical trial to evaluate efficacy and safety of horizontal positioning interventions to reduce pulmonary complications in mechanically ventilated critically ill adult patients. The hypothesis of the randomized controlled trial (RCT) is no difference in pulmonary complications between manual, 2-hourly lateral rotation to \> 45 degrees (control), and continuous automated turning to 45 degrees (experimental) groups.

Interventions

OTHERManual turn

Manual turn from side to back to side every 2 hours by nurses while patient receiving mechanical ventilation

DEVICEkinetic therapy bed

Continuous, automated turning to a maximum of 45 degrees in the lateral positions while the patient is receiving mechanical ventilation

Sponsors

Society of Critical Care Medicine
CollaboratorOTHER
The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* receiving mechanical ventilation * ability to place on study protocol within 8 hours of intubation

Exclusion criteria

* pulmonary mass, pneumothorax, hemothorax, pleural effusion, or other source of compression atelectasis at time of assessment for eligibility * systolic blood pressure \< 90 mmHg with vasopressor support * orthopedic injuries requiring limited or complete immobilization * head injury requiring intracranial pressure monitoring * unstable spinal injuries * rib fractures * body weight \> 350 lbs * intubation within the previous 2 weeks

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Pulmonary Complications.Participants were followed for the duration of ICU stay, an average of 10 days.Number of participants who did not have preventable pulmonary complications (PPC) on pre-study chest radiograph (CXR) and developed PPC during the study period. Pearson Chi-Square test used to test significance of difference between turning groups.

Secondary

MeasureTime frameDescription
Mechanical Ventilation Duration.Participants were followed for the duration of mechanical ventilation, an average of 5.5 days.Days on mechanical ventilation, from initiation to withdrawal of mechanical ventilation
ICU Length of Stay.Participants were followed for the duration of ICU stay, an average of 10 days.Time in days from study ICU admission to study ICU discharge or death
ICU All-cause Mortality.Participants were followed for the duration of ICU stay, an average of 10 days.Death from any reason between admission and discharge from study ICU
Turning-related EventsParticipants were followed for the duration of time on protocol, an average of 3.5 days.Non-serious adverse events that occurred during the time of rotation in the kinetic therapy bed group and during lateral rotation to right or left position in the manual turn group

Participant flow

Recruitment details

Recruitment period spanned 8.6 months (between 09/28/07 - 04/30/07 and 05/01/09 - 08/31/09) and was done in 2 ICUs of 2 tertiary hospitals. Recruitment efforts were intermittent due to staffing resources and reconfiguration and testing of automated turn bed angle sensor.

Pre-assignment details

Not applicable. All enrolled patients assigned to group.

Participants by arm

ArmCount
Kinetic Therapy Bed
Kinetic Therapy Bed: Continuous automated turning to 45 degrees with head of the bed elevated 30 degrees or more for up to 7 continuous days
8
Manual Turn
Manual Turn: lateral rotation every 2 hours from back to left to back to right to back, with \>/= 45 degree lateral rotation angle and 30 degree head of bed elevation for up to 7 consecutive days
8
Total16

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath01

Baseline characteristics

CharacteristicManual TurnTotalKinetic Therapy Bed
Age, Continuous54.3 years
STANDARD_DEVIATION 12.2
56.3 years
STANDARD_DEVIATION 11.5
58 years
STANDARD_DEVIATION 11.4
APACHE II27 Scores on a scale
STANDARD_DEVIATION 9
25 Scores on a scale
STANDARD_DEVIATION 6.7
24 Scores on a scale
STANDARD_DEVIATION 5
COPD Diagnosis
No
4 Participant12 Participant8 Participant
COPD Diagnosis
Yes
4 Participant4 Participant0 Participant
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants4 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
5 Participants12 Participants7 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
FIO20.77 Fraction
STANDARD_DEVIATION 0.28
0.75 Fraction
STANDARD_DEVIATION 0.26
0.73 Fraction
STANDARD_DEVIATION 0.25
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
1 Participants2 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
7 Participants13 Participants6 Participants
Sex: Female, Male
Female
5 Participants9 Participants4 Participants
Sex: Female, Male
Male
3 Participants7 Participants4 Participants
Surgery
No
6 Participant11 Participant5 Participant
Surgery
Yes
2 Participant5 Participant3 Participant
Vasopressor Use
Absence
5 Participant10 Participant5 Participant
Vasopressor Use
Presence
3 Participant6 Participant3 Participant

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
8 / 87 / 7
serious
Total, serious adverse events
4 / 83 / 7

Outcome results

Primary

Incidence of Pulmonary Complications.

Number of participants who did not have preventable pulmonary complications (PPC) on pre-study chest radiograph (CXR) and developed PPC during the study period. Pearson Chi-Square test used to test significance of difference between turning groups.

Time frame: Participants were followed for the duration of ICU stay, an average of 10 days.

Population: Intention to treat; all 8 patients enrolled in kinetic therapy bed turn and 7 of 8 patients enrolled in manual turn (1 died before protocol initiated)

ArmMeasureValue (NUMBER)
Kinetic Therapy BedIncidence of Pulmonary Complications.1 participants
Manual TurnIncidence of Pulmonary Complications.1 participants
Comparison: Pearson Chi-Square Test for difference between groupsp-value: 1Fisher Exact
Secondary

ICU All-cause Mortality.

Death from any reason between admission and discharge from study ICU

Time frame: Participants were followed for the duration of ICU stay, an average of 10 days.

Population: All 8 patients enrolled in the kinetic therapy bed group and 7 of the 8 patients enrolled in the manual turn group (1 patient died before start of study protocol)

ArmMeasureValue (NUMBER)
Kinetic Therapy BedICU All-cause Mortality.2 participants
Manual TurnICU All-cause Mortality.2 participants
p-value: 1Fisher Exact
Secondary

ICU Length of Stay.

Time in days from study ICU admission to study ICU discharge or death

Time frame: Participants were followed for the duration of ICU stay, an average of 10 days.

Population: All 8 patients enrolled in kinetic therapy bed group and 7 of 8 patients enrolled in manual turn group (1 patient enrolled but died before started on protocol)

ArmMeasureValue (MEDIAN)
Kinetic Therapy BedICU Length of Stay.11.1 Days
Manual TurnICU Length of Stay.8.2 Days
p-value: 0.451Wilcoxon (Mann-Whitney)
Secondary

Mechanical Ventilation Duration.

Days on mechanical ventilation, from initiation to withdrawal of mechanical ventilation

Time frame: Participants were followed for the duration of mechanical ventilation, an average of 5.5 days.

Population: All 8 patients enrolled in kinetic therapy bed group and 7 of 8 patients enrolled in manual turn group (1 death before study protocol initiated)

ArmMeasureValue (MEAN)Dispersion
Kinetic Therapy BedMechanical Ventilation Duration.5.97 DaysStandard Deviation 4.99
Manual TurnMechanical Ventilation Duration.5.21 DaysStandard Deviation 4.29
Comparison: There will be no difference in duration of mechanical ventilation between groups.p-value: 1Wilcoxon (Mann-Whitney)
Secondary

Turning-related Events

Non-serious adverse events that occurred during the time of rotation in the kinetic therapy bed group and during lateral rotation to right or left position in the manual turn group

Time frame: Participants were followed for the duration of time on protocol, an average of 3.5 days.

Population: All 8 patients enrolled in the kinetic therapy bed group and 7 of the 8 patients enrolled in the manual turn group (1 patient died after enrollment but before protocol could be initiated)

ArmMeasureValue (MEAN)Dispersion
Kinetic Therapy BedTurning-related Events138 EventsStandard Deviation 131
Manual TurnTurning-related Events125 EventsStandard Deviation 87
p-value: 1Wilcoxon (Mann-Whitney)

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026